| Name |
Deksametazon Zentiva 8 mg tablete |
| Marketing Authorisation Number |
HR-H-273384160 |
| Active Substance |
deksametazon |
| Composition |
jedna tableta sadrži 8 mg deksametazona |
| Pharmaceutical Form |
Tableta |
| Manufacturer |
S.C. Zentiva S.A., Bukurešt, Rumunjska |
| Marketing Authorisation Holder |
Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka |
| Marketing Authorisation Date |
19.12.2023 |
| MA Period of Validity |
19.12.2028 |
| Classification Number |
UP/I-530-09/22-01/219 |
| Registration Number |
381-12-01/171-23-07 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
H02AB02 |
| Marketing status |
Never marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
